Journal of Medicinal Chemistry
Volume 42, Issue 9 (May 6, 1999)
Copyright © 1999
American Chemical Society
| PERSPECTIVE | |
1481-1500 | Emerging Molecular Approaches to Pain Therapy
|
|
COMMUNICATIONS TO THE EDITOR | |
1501-1504 | Potent Estrogenic Agonists Bearing Dicarba-closo-dodecaborane as a Hydrophobic Pharmacophore
|
|
ARTICLES | |
1505-1514 | SQ: A Program for Rapidly Producing Pharmacophorically Relevent Molecular Superpositions
|
1515-1524 | Novel Approach To Predicting P450-Mediated Drug Metabolism: Development of a Combined Protein and Pharmacophore Model for CYP2D6
|
1525-1536 | Synthesis of a Series of Stromelysin-Selective Thiadiazole Urea Matrix Metalloproteinase Inhibitors
|
1537-1545 | Comparative Molecular Field Analysis of Hydantoin Binding to the Neuronal Voltage-Dependent Sodium Channel
|
1546-1555 | Agonist Selectivity of mGluR1 and mGluR2 Metabotropic Receptors: A Different Environment but Similar Recognition of an Extended Glutamate Conformation
|
1556-1575 | Novel Potent and Selective Central 5-HT3 Receptor Ligands Provided with Different Intrinsic Efficacy. 2. Molecular Basis of the Intrinsic Efficacy of Arylpiperazine Derivatives at the Central 5-HT3 Receptors
|
1576-1586 | Development of Fluorine-18-Labeled 5-HT1A Antagonists
|
1587-1603 | Design and Synthesis of Imidazoline Derivatives Active on Glucose Homeostasis in a Rat Model of Type II Diabetes. 2. Syntheses and Biological Activities of 1,4-Dialkyl-, 1,4-Dibenzyl, and 1-Benzyl-4-alkyl-2-(4',5'-dihydro-1'H- imidazol-2'-yl)piperazines and Isosteric Analogues of Imidazoline
|
1604-1614 | cycloSal-Pronucleotides of 2',3'-Dideoxyadenosine and 2',3'-Dideoxy-2',3'-didehydroadenosine: Synthesis and Antiviral Evaluation of a Highly Efficient Nucleotide Delivery System
|
1615-1624 | cycloSal-Pronucleotides of 2'-Fluoro-ara- and 2'-Fluoro-ribo-2',3'- dideoxyadenosine as a Strategy to Bypass a Metabolic Blockade
|
1625-1638 | Structure-Activity Relationships of Bisphosphate Nucleotide Derivatives as P2Y1 Receptor Antagonists and Partial Agonists
|
1639-1647 | Cyclobutane Quisqualic Acid Analogues as Selective mGluR5a Metabotropic Glutamic Acid Receptor Ligands
|
1648-1660 | Novel Derivatives of 2-Pyridinemethylamine as Selective, Potent, and Orally Active Agonists at 5-HT1A Receptors
|
1661-1666 | Synthesis of 2,8-Disubstituted Imidazo[1,5-a]pyrimidines with Potent Antitumor Activity
|
|
BRIEF ARTICLES | |
1667-1672 | Potent 1,3-Disubstituted-9H-pyrido[3,4-b]indoles as New Lead Compounds in Antifilarial Chemotherapy
|
1673-1679 |  Opioid Affinity and Selectivity of 4-Hydroxy-3-methoxyindolomorphinan Analogues Related to Naltrindole
|
|
BOOK REVIEWS | |
1680-1680 | Phytomedicines of Europe. Chemistry and Biological Activity. ACS Symposium Series 691 Edited by Larry D. Lawson and Rudolf Bauer. American Chemical Society, Washington, DC. 1998. x + 324 pp. 15.5 × 23.5 cm. ISBN 0-8412-3559-7. $115.00.
|
1681-1681 | Medicinal Chemistry: Today and Tomorrow Edited by Mikio Yamazaki. International Union of Pure and Applied Chemistry, Blackwell Science Ltd., Oxford. 1997. x + 278 pp. 19.5 × 23 cm. ISBN 0-632-04272-9.  55.00.
|
1681-1681 | Designer Drugs Directory By Karel Valter and Philippe Arrizabalaga. Edited by Jean-Claude Landry. Elsevier Science, Lausanne, Switzerland. 1998. 212 pp. 17 x 25 cm. ISBN 0-444-20525-X. $154.00.
|
|
ADDITIONS AND CORRECTIONS | |
1682-1682 | Novel CDC25A Phosphatase Inhibitors from Pyrolysis of 3- -Azido-B-homo-6-oxa-4-cholesten-7-one on Silica Gel
|
1682-1682 | Substrate Specificity and Stereoselectivity of Rat Brain Microsomal Anandamide Amidohydrolase
|